IMMD

IMMD is a drug discovery company with a leading-edge rational drug design technology. Its high capability greatly owes to the excellence of its proprietary software system. The technology enabled IMMD to identify dozens of drug seeds by virtual screening, to select promising seeds and to optimize the seeds by minimum syntheses strategically, based... on estimated docking mode to the target. The advantages of the method were proved by several successes of drug discovery from the collaboration research with partners as well as from its in-house programs. IMMD was founded by Dr. Akiko Itai in 1995 focusing on its rational drug design technology. As a former professor of the Faculty of Pharmaceutical Sciences at the University of Tokyo, she is internationally recognized for her contributions to novel methodologies of rational drug design. IMMD's drug discovery business is conducted by using its proprietary drug discovery technology. It is used for all of the following three business categories.Read More